BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He L, Wang S, Peng L, Zhao H, Li S, Han X, Habimana JD, Chen Z, Wang C, Peng Y, Peng H, Xie Y, Lei L, Deng Q, Wan L, Wan N, Yuan H, Gong Y, Zou G, Li Z, Tang B, Jiang H. CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells. Transl Psychiatry 2021;11:479. [PMID: 34535635 DOI: 10.1038/s41398-021-01605-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Martinez-rojas VA, Juarez-hernandez LJ, Musio C. Ion channels and neuronal excitability in polyglutamine neurodegenerative diseases. Biomolecular Concepts 2022;13:183-199. [DOI: 10.1515/bmc-2022-0018] [Reference Citation Analysis]
2 Karwacka M, Olejniczak M. Advances in Modeling Polyglutamine Diseases Using Genome Editing Tools. Cells 2022;11:517. [DOI: 10.3390/cells11030517] [Reference Citation Analysis]